![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 48, 44695-44703, November 30, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-Latrotoxin, Acting via Two
Ca2+-dependent Pathways, Triggers Exocytosis of
Two Pools of Synaptic Vesicles*
,
,
,
§,
,
**
From the
Biochemistry Department, Imperial College,
Exhibition Road, London SW7 2AY, United Kingdom, the ¶ Laboratoire
de Neurobiologie des Canaux Ioniques, INSERM U464, Faculté de
Médecine Secteur Nord, Boulevard Pierre Dramard, F-139 16 Marseille Cedex 20, France, and the
Division of Neurophysiology,
National Institute for Medical Research,
London NW7 1AA, United Kingdom
Received for publication, August 22, 2001
| |
ABSTRACT |
|---|
|
|
|---|
However, LTX has a complex mode of action. First, it binds to, and
could activate, two unrelated neuronal receptors: neurexins (NRX) (5)
and latrophilin (LPH) (6). Second, LTX forms large pores in the plasma
membrane of receptor-expressing cells (7-10). These pores cause
massive influx of Ca2+ with subsequent stimulation of
exocytosis (1, 2, 11, 12), influx/efflux of other cations (7), efflux
of NTs (8, 13, 14), and eventual disruption of cell morphology and
function (15, 16). Therefore, to study any potential signaling mediated by the receptor(s), it is important to avoid toxin pore formation.
As we demonstrated recently, the toxin forms pores by assembling into
cyclical tetramers, which insert into lipid bilayers (17). By using a
LTX preparation that formed tetramers/pores only in the presence of
Mg2+, we selectively studied the receptor-mediated LTX
action in synaptosomes (8, 18, 19) and found that LTX-receptor
interaction in the absence of pore formation causes norepinephrine (NE)
exocytosis that requires both extracellular and stored
Ca2+. On the other hand, release of amino acid (AA)
transmitters, which mediate fast neurotransmission in the brain, could
involve other mechanisms.
Therefore, the current work had two main objectives: to investigate the
mechanism of LTX-induced release of L-glutamic acid (Glu)
and Materials--
Amino Acid Release from Synaptosomes--
Rat cerebrocortical
synaptosomes, prepared as described (20), were suspended in
physiological buffer (PB, containing, in mM: 125 NaCl, 5 KCl, 1 MgCl2, 10 glucose, 0.1 aminooxyacetic acid, and 25 HEPES, pH 7.4) supplemented with 2 mM CaCl2 and
kept on ice until required. All buffers and suspensions were constantly oxygenated. In the short loading procedure, synaptosomes
were incubated with 2-5 µCi/ml [3H]GABA or
[14C]Glu at 37 °C for 5 min, washed, and stimulated 20 min later to reproduce conditions used by others (21). In the
normal loading protocol, terminals were incubated for 5 min
with [14C]Glu and for 60 min with [3H]GABA,
washed, and incubated for 1 h at 37 °C in PB containing 0.1 mM EGTA (20).
During the post-loading incubation, some synaptosomes were treated
with: 400 nM BoNT/E (2 h, eliminating 90% of SNAP-25)
(20), 100 µM BAPTA-AM (1 h) (20), 1 µM BAF
(1 h) (22), 10 µM U73122 (15 min), 10 µM TG
(30 min, no less TG is required to cause specific effects in brain
preparations) (23, 24), or 3 µM phenylarsine oxide (PAO,
15 min) (21). The latter three drugs were also included in subsequent
buffers. Control samples were treated identically, using the drug-free
solvents. Exposure to PAO did not exceed 25-35 min. In the short
loading protocol, PAO was added 10 min before [14C]Glu,
and this did not perturb NT uptake (21).
To evoke release, PB containing a stimulus (with Ca2+ or
0.1 mM EGTA) was added to synaptosomes at 24 °C; basal
Ca2+-independent release was determined using stimulus-free
PB/EGTA. For quick and thorough mixing and to prevent NT reuptake (20, 25), synaptosomes (10-25 µg of protein) were diluted by the stimulus
8-fold. Using high K+, maximal release was achieved at 25 mM K+. A23187 in dimethyl sulfoxide was diluted
into Ca2+-containing PB 10 s before use. For
comparison with superfusion studies where terminals were
exposed to LTX for 1 min and release was evaluated over a longer period
(21), some samples were stimulated for 1 min and then diluted 5-fold,
resulting in subnanomolar LTX present during release measurements.
Hypertonic stimulation was done by adding sucrose in PB/EGTA to a final
concentration of 150 mM, which induced maximal vesicular
release (identified using BAF); higher [sucrose] only intensified
nonvesicular NT efflux.
To terminate Ca2+-dependent release, EGTA was
added to 0.1 mM free concentration. LTX-evoked
Ca2+-independent release was stopped by 0.1 mM
LaCl3. Sucrose-stimulated samples were returned to isotonic
conditions by adding low sodium PB. Prestimulation with high
K+ was stopped by dilution with potassium-free PB. Samples
were then centrifuged for 30 s, and the supernatant was recovered
immediately. The radioactivity of the supernatant and pellet was
determined by liquid scintillation counting. Phase 1 of
LTX-evoked AA release was measured during the first 2 min for
[14C]Glu and 1 min for [3H]GABA or over 5 min in the presence of La3+ for both AAs (both methods gave
same results). Phase 2 was determined by subtracting phase 1 from the aggregate Ca2+-dependent release over
5 min (phases 1 and 2).
Production of Recombinant Toxins--
LTXWT and
LTXN4C for baculovirus expression (26) were made similar to
those described previously (27), except no poly-His tags were
introduced (for better resemblance of native LTX). The recombinant toxins were purified from culture medium by affinity chromatography on
an anti-LTX monoclonal antibody (kind gift of Prof. E. V. Grishin) attached to CNBr-activated Sepharose (Amersham Pharmacia Biotech). The
toxins were eluted with 1 M MgCl2 and dialyzed
against PB.
Electron Microscopy and Image Processing--
Cryo-electron
microscopy (cryo-EM) and data analysis were carried out as described
(17).
LTX Pore Formation--
LTX-stimulated influx of
45Ca2+ into synaptosomes was measured as
described (8). For electrophysiological detection of LTX channels (9),
baby hamster kidney (BHK) cells were transiently transfected with LPH
(10) or an empty vector, mixed with a plasmid encoding green
fluorescent protein (used to identify transfected cells). Whole-cell
current recordings were performed 24 h later on isolated cells,
using wide-tipped patch pipettes (1.5-3 megohms). Where indicated in
figures, cells were perfused at 70 µl/min, using a local multichannel
superfusion system. pClamp 6 software was used for experimental
protocols and Biopatch for analysis. Whole-cell current traces are
shown without leak subtraction, after low pass filtering.
Electrophysiological Recordings in Hippocampal
Slices--
Immediately after extraction, 10-12-day-old rat brains
were placed in ice-cold oxygenated artificial cerebrospinal fluid (also used for recordings) containing (in mM): 135 NaCl, 3 KCl, 2 CaCl2, 10 HEPES-Na, 2 MgSO4, 25 NaHCO3, 25 glucose, pH 7.3. Transverse vibratome-cut
hippocampal slices (200 µm) were oxygenated for 1 h at 32 °C
and then at room temperature until used. Slices were transferred to a
perfused recording chamber mounted on an Axioskop 1FS microscope
(Zeiss) equipped with a 40× Achroplan objective. The bath solution
(32 °C) was oxygenated by a surface stream of hydrated
O2. Whole-cell patch-clamp recordings, in voltage clamp conditions ( Statistical Analysis--
The values in the figures are the
means from several independent experiments done on multiple samples,
with error bars indicating the S.E. Statistical significance of
differences between control and test values (probability that the
values are equal) was assessed by paired Student's t test
(p values are shown near the respective points; NS,
nonsignificant) or by the Kolmogorov-Smirnov two-sample test.
Loading Synaptosomes with Radiolabeled Transmitters--
To detect
synaptosomal release of AAs, we chose a batch (versus
superfusion) method, because it allows simultaneous and fast measurement of multiple samples and improves statistical evaluation of
data. This assay yielded results comparable with fast superfusion (6 ml/min) (25).
When synaptosomes were incubated with [14C]Glu at
37 °C, a maximal radioactivity uptake was achieved in 5 min (data
not shown). Labeled NT, taken up into the cytosol, requires some time
to equilibrate with the vesicles. Therefore, in such short-loaded
synaptosomes, vesicular release evoked by high K+ in a
Ca2+-dependent manner was initially small but
gradually increased upon further incubation at 37 °C and then
remained stable for several hours (Fig.
1A). In contrast, a
Ca2+-independent (probably cytosolic) component decreased
with time (Fig. 1B). For [3H]GABA, the optimal
loading/post-loading period was 120 min (data not shown). This
optimized ("normal") loading protocol was used in most experiments
below.
These results, in agreement with the earlier findings (28, 29), suggest
that radiolabeled cytosolic NT first enters a limited number of
vesicles but, with time, accumulates in a larger SV population.
LTX Evokes Three Distinct Types of AA Release--
In synaptosomes
loaded by the normal procedure, LTX triggered both
Ca2+-dependent and -independent AA release
(Fig. 1, C and D). To accurately determine the
amount and properties of these types of release, secretion had to be
terminated rapidly and selectively prior to the separation step (see
"Experimental Procedures"). Addition of EGTA instantly stopped the
Ca2+-dependent effect of LTX (Fig.
1C) but could not prevent its Ca2+-independent
action. We found, however, that 0.1 mM La3+
blocked the latter release immediately and completely (Fig.
1D) (3, 30). When mixed with LTX before synaptosomal
intoxication, La3+ also prevented all evoked
Ca2+-independent release (Fig.
2, A and B).
Measured using this method, the Ca2+-independent AA
secretion increased with LTX dose but always occurred at a constant
rate.
In contrast, the Ca2+-dependent LTX-evoked
release was not linear with time (Fig. 1C) and displayed two
temporally separated phases (Fig. 2, C-F). Phase 1 was
observed during the first 1-2 min after the addition of LTX and was
the only Ca2+-dependent release detectable at
low [Ca2+]e (Fig. 2, C and
D). At higher [Ca2+]e, a delayed
phase of secretion appeared (Fig. 2, E and F),
although for [3H]GABA it partially overlapped with phase
1 (Fig. 2F). Ca2+e requirements of
the two phases (Fig. 2, G and H) demonstrate that
phase 1 reaches a maximum at 0.2-0.4 mM Ca2+,
whereas a full expression of phase 2 requires more than 1 mM Ca2+. Most remarkably, La3+
abolished phase 2 of AA release but did not affect phase 1 (Fig. 2,
C-F).
To compare the rates of the fast Ca2+-dependent
and Ca2+-independent LTX actions, we used 5 nM
LTX and determined a higher resolution time course. Under these
conditions, phase 1 was complete in 30 s, with up to 2.9 ± 0.9% of total [14C]Glu being released within the first
15 s. Importantly, no Ca2+-independent release could
be detected at these times, indicating that phase 1 of the
Ca2+-dependent component is the fastest type of
LTX-stimulated secretion.
La3+ Perturbs the Pore-dependent Release by
Affecting LTX Tetramers--
La3+ blocks two types of
LTX-evoked AA release: Ca2+-independent and delayed
Ca2+-dependent. In noradrenergic terminals,
these release types require the presence of LTX pores (19). Together,
these findings suggest that La3+ inhibits AA release by
affecting LTX pores. To examine any direct interaction of this cation
with toxin pores, while excluding the involvement of nonreceptor
neuronal proteins, we used BHK cells. In such cells transfected with
LTX receptors, the toxin induces large pores (9). Addition of
La3+ to the bath quickly inhibited conductance of these
pores (Fig. 3A). This
inhibitory effect was fully reversible upon washout, indicating that
La3+ acts extracellularly and does not permanently damage
LTX.
LTX pores are formed by toxin tetramers inserting into the membrane
(17), and La3+ is likely to block such pores by perturbing
the tetramers. We studied the effect of La3+ on LTX
structure by cryo-EM and found that only <10% of all molecules in a
La3+-treated LTX sample were tetrameric, compared with
90-95% in control toxin (Fig. 3B). Furthermore, the few
tetramers still found in 0.1 mM La3+ were
grossly deformed; the shapes and relative positions of monomers became
clearly altered, resulting in a nearly complete closure of the central
pore (10-25 Å in control and
Combined, these results indicate that La3+ inhibits some
LTX actions by affecting the toxin pores and that both the
Ca2+-independent and the delayed
Ca2+-dependent components of LTX-evoked AA
release rely on the presence of such pores. In contrast, the fast
Ca2+-dependent phase does not require LTX pore formation.
Only Ca2+-dependent LTX-evoked Release Is
Vesicular--
Because LTX pores are permeable to NTs (10), we checked
whether any LTX-evoked release of radiolabeled AAs was caused by leakage through such pores. To identify vesicular secretion, we used
two drugs: (i) BoNT/E, which cleaves SNAP 25, a SNARE
(soluble N-ethylmaleimide-sensitive factor
attachment protein receptor) protein essential
for exocytosis; and (ii) BAF, which blocks the vacuolar-type proton
pump and prevents NT loading into SVs, thus decreasing measured
exocytosis (22). Both reagents inhibited the
Ca2+-dependent AA release stimulated by high
K+ or Ca2+ ionophore, A23187 (Fig.
4, A-D). Similarly, these
drugs blocked the Ca2+-dependent component of
LTX action (Fig. 4, E and F). Moreover, both the
slow and fast Ca2+-dependent components of
LTX-evoked release were abolished (Fig. 4, I-L), confirming
their exocytotic nature.
In contrast, the Ca2+-independent LTX-evoked AA release was
unperturbed in botulinized or BAF-treated terminals (Fig. 4,
G and H), implying that the bulk of such release
does not occur via conventional exocytosis. Because this type of
release strictly depends on LTX pore formation (Figs. 2 and 3), we term
it below "LTX-evoked pore-mediated efflux."
Ca2+-dependent Components of LTX-evoked
Release Require Intracellular Ca2+
(Ca2+i)--
To further characterize the
two types of Ca2+-dependent LTX-stimulated
exocytosis, we asked whether Ca2+ acted as an extracellular
co-factor for LTX or was required in the cytosol. Preloading
synaptosomes with BAPTA substantially reduced the
Ca2+-dependent AA release triggered by high
K+ or by A23187 (Fig. 5,
A-D), and inhibited both components of
Ca2+-dependent LTX-evoked release (Fig. 4,
E, F, H, and I). Thus, cytosolic Ca2+ is necessary for all
Ca2+-dependent LTX actions.
The Ca2+-independent LTX-evoked AA efflux has no
Ca2+ requirement, and BAPTA-loaded terminals actually
exhibited a larger amount of such release (Fig. 4, K and
L).
Only the Fast Phase of Ca2+-dependent
LTX-evoked Release Requires Ca2+ Stores and Phospholipase C
(PLC)--
Cytosolic Ca2+ that participates in LTX actions
may, at least in part, come from intracellular Ca2+ stores
known to play an important role in LTX-triggered release of NE (8, 18,
19). Therefore, prior to stimulation with LTX, we depleted
Ca2+ stores with TG. As a result, the fast phase of
Ca2+-dependent LTX-evoked
[14C]Glu release was greatly attenuated (Fig.
5G), whereas the delayed phase was not affected (Fig.
5J). Some intracellular Ca2+ stores can be
mobilized by inositol trisphosphate, a product of PLC action. Indeed,
inhibition of PLC by U73122 blocked the fast (Fig. 5G), but
not the slow (Fig. 5J), phase of [14C]Glu
release. Importantly, neither TG nor U73122 acted by simply causing
depletion of vesicles, which could still be stimulated by sucrose (both
AAs; data not shown). Thus, phase 1 may involve PLC-mediated
mobilization of Ca2+i, whereas phase
2 is probably triggered directly by Ca2+ entering through
the LTX pore.
As expected, the Ca2+-independent LTX pore-mediated release
was unaffected by TG or U73122, indicating that this pathway does not
involve Ca2+ stores or PLC (Fig. 5M).
Non-pore-forming LTX Mutant Evokes Fast
Ca2+-dependent Exocytosis--
Thus, the fast
phase of LTX-stimulated release did not involve pore formation but
required mobilization of Ca2+i, a
process that can be induced by receptor signaling (8, 27). However, a
possibility remained that some LTX pores were not completely blocked by
La3+. Therefore, to ascertain that phase 1 involves LTX
receptor signaling, a toxin was needed that lacked any ability to form
membrane pores. Coincidentally, an interesting LTX mutant
(LTXN4C) had been described that bound to both LTX
receptors and activated PLC but did not cause any
Ca2+-independent secretion from synaptosomes (27).
Because LTX pores are responsible for Ca2+-independent
release (Figs. 2 and 3), we hypothesized that LTXN4C was
inactive in the absence of Ca2+ because it could not form
pores. To test this hypothesis, we compared the pore-forming activities
of LTXN4C and recombinant wild type toxin
(LTXWT) by measuring influx of
45Ca2+ into synaptosomes. Addition of
LTXWT (or native LTX; data not shown) caused
45Ca2+ accumulation in the terminals (Fig.
6A). In contrast,
LTXN4C did not induce any Ca2+ influx (Fig.
6A). This result was confirmed by single-channel patch-clamp
recordings in BHK cells expressing exogenous receptors. LTXN4C was incapable of forming pores in these cells (Fig.
6B), whereas LTXWT, added after the mutant,
induced pores very efficiently (Fig. 6B), indicating that
the inability to form pores was the feature of LTXN4C and
not the cells.
We then compared the actions of both recombinant toxins on AA release.
LTXWT mimicked the native toxin and triggered all three
components of release in synaptosomes (Fig. 6, C-H). In
contrast, LTXN4C failed to induce both the delayed phase of
Ca2+-dependent secretion and the
Ca2+-independent pore-mediated efflux (Fig. 6,
E-H). Strikingly, the mutant was equipotent with
LTXWT in stimulating the fast phase of
Ca2+-dependent AA exocytosis (Fig. 6,
C and D). Patch-clamp recordings in CA3 neurons
of rat hippocampal slices unequivocally demonstrated that, in the
presence of Ca2+, LTXN4C causes a strong
increase in the frequency of Glu-mediated asynchronous miniature events
without altering their amplitudes (Fig. 6, I-K).
Our data indicate that LTXN4C is capable of triggering AA
exocytosis (phase 1) without forming pores but by interacting with the
toxin receptor(s).
The Delayed Ca2+-dependent LTX-evoked
Release Requires Active PI 4-Kinase--
Because the two
Ca2+-dependent phases had different
pharmacological properties and time courses, they could involve
different SV pools. Some NE-containing vesicles require active PI
4-kinase, and Ca2+-dependent LTX-evoked NE
release is sensitive to an inhibitor of this enzyme, PAO (19, 21, 31).
If AAs are released via a similar mechanism, their secretion must also
be perturbed by PAO.
When testing this drug, we found that it considerably inhibited
Ca2+-dependent [14C]Glu release
evoked by high K+ or A23187 (Fig.
7, A and B). As
reported previously (21), PAO had no effect on the
Ca2+-independent release triggered by sucrose (Fig.
7C) or LTX (Fig. 7, H and I).
However, when comparing the sensitivities to PAO of the two
Ca2+-dependent phases of LTX-evoked AA release,
we observed an interesting effect; surprisingly, the fast phase was
unaltered (Fig. 7, D and E), whereas phase 2 was
blocked completely (Fig. 7, F and G), indicating
that these types of Ca2+-dependent release
occur from vesicular pools with different sensitivities to PAO.
The Fast Ca2+-dependent LTX-evoked Release
Occurs from a Fast-loading Pool of Vesicles--
Our results employing
PAO agreed with previous findings for endogenous Glu secretion (31),
whereas some authors did not observe any PAO-sensitive release of
radiolabeled AAs (21). We noted, however, that the latter group had
labeled synaptosomes for only 5 min, while our normal protocol required
long post-loading periods (Fig. 1). We speculated that the length of
loading might differentiate between vesicular pools with fast and slow
loading kinetics. Therefore, we tested the effect of LTX on the
"short-loaded" synaptosomes. Interestingly, short loading did not
affect significantly phase 1 but abolished phase 2 of
Ca2+-dependent LTX-evoked AA exocytosis (Fig.
7, D-G). Evidently, the latter phase occurs from a distinct
SV pool that slowly accumulates radioactive AAs from the cytosol. The
Ca2+-independent LTX pore-mediated AA efflux was similar in
terminals loaded by either procedure (Fig. 7, H and
I), further demonstrating that the
Ca2+-dependent and -independent types of
release occur from different NT pools.
We then tested whether the SV pool involved in the fast
Ca2+-dependent LTX action retained its
pharmacological features in such short-loaded terminals. As after the
normal loading procedure, PAO still did not affect the fast
Ca2+-dependent LTX exocytosis, whereas TG
greatly attenuated it (Fig. 7E). As expected, the slow
Ca2+-dependent component remained nonexistent
(Fig. 7G), and neither drug affected the
Ca2+-independent LTX pore-mediated Glu efflux (Fig.
7I). The same results were obtained in similar experiments
with GABA (data not shown).
These findings indicate that the fast
Ca2+-dependent LTX-evoked exocytosis occurs
from a fast-loading vesicular pool that may require intact
Ca2+ stores but not PI 4-kinase.
The Fast Phase of LTX-evoked Release Occurs from Sucrose- and
Depolarization-sensitive Vesicles--
Being PAO-insensitive, phase 1 of Ca2+-dependent LTX exocytosis must occur
from SVs that have already undergone PI 4-kinase-dependent priming. These vesicles may belong to the readily releasable pool (RRP)
distinguished by its sensitivity to sucrose (32, 33). We found that 150 mM sucrose stimulated Ca2+-independent
[14C]Glu release from synaptosomes (~9% of total AA
content; e.g. Fig. 7C, control); this
secretion was largely vesicular because pretreatment of terminals with
BAF decreased it by 65 ±15%. Interestingly, the amount of AAs
released by sucrose did not depend on the loading time or the length of
stimulation (3-90 s; data not shown). However, the length of such
stimulation had a profound effect on the efficacy of a second stimulus
applied within 4 min (see Fig. 8,
top panel, for experimental design): terminals stimulated
first for 3 s produced the same release as untreated synaptosomes
when challenged with sucrose for a second time (Fig. 8, A
and B). In contrast, a prolonged (90 s) first stimulation
strongly inhibited further sucrose-induced release (Fig. 8,
A and B). Sensitivity to hypertonic solutions recovered slowly after 4 min.
This temporary depression of the RRP, similar to that observed
previously (34-36), allowed us to test whether sucrose and
Ca2+-dependent LTX mechanisms acted on the same
SV pool. We found that a 90-s prestimulation with sucrose drastically
reduced the subsequent Ca2+-dependent LTX phase
1 of [14C]Glu exocytosis (measured with or without
La3+), whereas phase 2 remained unperturbed (Fig. 8,
C and D). In a reverse experiment, to avoid
irreversible pore formation by native LTX, we used LTXN4C
(in the presence of Ca2+). The mutant strongly inhibited
subsequent Ca2+-independent release triggered by sucrose
(Fig. 8F). Sucrose and LTXN4C also reciprocally
perturbed each other's action in the short-loaded synaptosomes, in
which only the fast-loading vesicles contained [14C]Glu
(Fig. 8, G, H, and J). Very similar
data were obtained with [3H]GABA (data not shown).
Combined, these results strongly suggest that sucrose and the fast LTX
mechanism act on the same vesicular pool.
Interestingly, predepolarization of synaptosomes with high
K+ inhibited the stimulation of this pool by LTX or sucrose
(Fig. 8, K and N). In contrast, pretreatment with
sucrose or high K+ had no effect on either the slow
Ca2+-dependent (Fig. 8, D,
H, and L) or the Ca2+-independent
(Fig. 8, E, I, and M) LTX-evoked AA
release, indicating that these types of release do not involve the
RRP.
Pore-dependent and -independent LTX Actions--
Of
the two modes of LTX action (pore formation and receptor stimulation),
the former is likely to cause the strongest effect. Indeed, large LTX
pores (10-25 Å) (17), permeable to cations and NTs (7, 8, 13, 14),
must perturb membrane potential, energy level, and cation balance in
excitable cells (7, 13, 37) and cause cell/terminal
death2 (15, 16).
Nevertheless, many studies have concluded that LTX interaction with its
receptor(s) can facilitate exocytosis (2, 4, 38, 39). Obviously, more
reliable results can be obtained if pore formation is precluded. This
has been achieved here by blocking LTX pores with La3+ and
by using LTXN4C, which cannot form pores.
Trivalent cations can block LTX-evoked release, and this rapid,
extracellular, and reversible inhibitory action (Figs. 1D and 3A) has been always attributed to the blockade of LTX
pores (3, 7, 30). We have now revealed the molecular mechanism of this
inhibition; La3+, likely residing in the pore center,
induces conformational changes in LTX tetramers/pores, leading to the
closure of the central channel and tetramer dissociation (Fig. 3,
B and C). As a result, this cation selectively
inhibits such AA release that depends on LTX pores: (i) exocytosis
evoked by Ca2+ entry (Fig. 2, E and
F) and (ii) nonvesicular efflux of cytosolic AAs (Fig. 2,
A and B). In contrast, LTX binding to the
receptors persists in 0.1 mM La3+ (27, 30) and
could lead to receptor activation. Consistent with this idea and in
agreement with the earlier findings (2, 40), some LTX actions are not
blocked by La3+ (Fig. 2, C-F).
To avoid any direct effect of La3+ on synaptosomal
secretion, we employed the LTX mutant. LTXN4C has ideal
qualities; it binds to LPH and NRX and stimulates hydrolysis of
phosphoinositides (27), but does not form pores (Fig. 6, A and B) or trigger Ca2+-independent
NT release (27) (Fig. 6, G and H). We have now demonstrated3 that
LTXN4C does not form pores because it cannot tetramerize.
Consistent with that, LTXN4C fails to stimulate those
events that require pore formation (Fig. 6, E-H) but causes
receptor-mediated secretion (Fig. 6, C, D, and
I).
Three Types of LTX-stimulated Release--
We have identified here
at least three components of LTX action in synaptosomes: one
Ca2+-independent and two
Ca2+-dependent pathways (Fig. 2). These release
types have very different properties and principal mechanisms and
require a systematic analysis (as detailed below).
Ca2+-independent LTX-evoked
Release--
Electrophysiologically detected quantal secretion caused
by LTX in the absence of Ca2+ is weaker than the
Ca2+-dependent exocytosis (2, 11, 12). In
synaptosomes, however, the Ca2+-independent LTX action is
inconsistently strong (27) and must (at least in part) come from the
cytosol. Indeed, the cytosol contains >80% of endogenous synaptic AAs
(37) that are used to refill SVs (41); in short-loaded synaptosomes,
the radiolabeled cytosolic pool is even larger (see Fig. 1,
A and B). Furthermore, the
Ca2+-independent LTX-evoked release of several transmitters
(NE, Glu, and GABA) biochemically measured in synaptosomes is
insensitive to inhibitors of exocytosis: (i) clostridial neurotoxins
(8) (Fig. 4), (ii) BAF (Fig. 4), or (iii) hypertonic or hyperkalemic overstimulation (Fig. 8). Together, these results indicate that the
Ca2+-independent LTX effect in synaptosomes is largely
nonvesicular. Being strictly dependent on the NT-permeable LTX pores,
Ca2+-independent AA release is likely to represent leakage
through such pores.
This seems to contradict electrophysiological recordings in tissue
preparations clearly demonstrating vesicular release triggered by LTX
in "zero" Ca2+ (e.g. Ref. 1). However,
unlike release observed in synaptosomes, this secretion is blocked by
clostridial toxins (2). In addition, Ca2+-independent
quantal release evoked by LTX is 500-1000 times lower than that
induced by sucrose (2). Therefore, although sucrose-stimulated secretion is detectable biochemically (~8-10% of the total
synaptosomal pool; Figs. 7C and 8 (A and
B)), the Ca2+-independent LTX-evoked exocytosis
(~0.02%) is below the detection limit of radioassay.
Two Phases of Ca2+-dependent LTX
Action--
In our experiments, the aggregate
Ca2+-dependent LTX-stimulated release over 5 min constitutes (percentage of total content) 10.3 ± 2.0 for Glu
and 11.8 ± 1.9 for GABA, which is compatible with the maximal
amount of endogenous Glu that could be released from synaptosomes in a
Ca2+-dependent fashion (8-16%) (29, 42). As
verified by BoNT and BAF treatment (Fig. 4), the
Ca2+-dependent components of LTX-triggered
release are vesicular.
Our findings corroborate and extend the previously published data (21,
27, 43). (i) In addition to the Ca2+-independent AA release
seen by these authors, we have now detected the
Ca2+-dependent component, always observed
electrophysiologically; (ii) having confirmed that LTXN4C
is inactive in the absence of Ca2+, we have also found that
it causes Ca2+-dependent exocytosis; (iii)
having explained how La3+ inhibits the
Ca2+-independent release (27), we have now demonstrated
that the cation does not block the fast
Ca2+-dependent action (as reported previously
(40)). Several factors have allowed us to observe the
Ca2+-dependent LTX actions. (i) Long loading of
synaptosomes labeled the depot vesicles and revealed phase 2 (Figs. 2
(E-H) and 7F); (ii) instantaneous termination of
release allowed us to detect the fast phase 1 of LTX action, usually
lost with slow superfusion (<1 ml/min) (25); (iii) avoiding
prestimulation of synaptosomes with high K+ before adding
LTX preserved phase 1 (Fig. 8K).
Remarkably, we have also been able to divide the
Ca2+-dependent LTX-evoked exocytosis into two
temporally distinct phases. These phases have different pharmacological
characteristics and, consequently, different underlying mechanisms.
Phase 1 (i) is complete within 30-60 s after the addition of LTX (Fig.
2, C-F), (ii) requires <0.4 mM
Ca2+e (Fig. 2, G and H),
(iii) is independent of the toxin pore (not blocked by
La3+), (iv) depends on internal Ca2+ stores and
active PLC (Fig. 5G), and (v) is stimulated by
LTXN4C (Fig. 6, C and D). Phase 2 (i)
is delayed, producing detectable release only 2-4 min after LTX
addition (Fig. 2, E and F), (ii) requires >1
mM Ca2+e, (iii) is sensitive to
La3+, (iv) is insensitive to disruption of Ca2+
stores and inhibition of PLC (Fig. 5J), and (v) is not
evoked by LTXN4C (Fig. 6, E and F).
Phase 1, therefore, does not involve LTX pore formation, whereas phase
2 is probably caused by pore-mediated Ca2+ accumulation in
the cytosol (Fig. 6A).
An important question arises about the nature of the fast phase. Is it
evoked by toxin's partial internalization and direct activation of
some exocytotic proteins (44) or is it mediated by the receptor(s)? The
former hypothesis seems to be unlikely because (i) toxin
internalization cannot be faster than pore formation and (ii) the
mutant toxin, which is unable to internalize (44), still stimulates
this phase of release upon binding to the receptors (Fig. 6).
Therefore, this release must involve some receptor-transduced signaling.
Receptor-mediated Exocytosis--
What could be the mechanism of
LTX receptor-mediated Ca2+-dependent AA
release? As with the Ca2+-dependent release of
NE (8), this component is sensitive to TG and U73122 (Figs.
5G and 7E), implicating internal Ca2+
stores and PLC. Activation of PLC by either LTXWT or
LTXN4C (27) has features remarkably similar to those of the
fast phase of AA release (Fig. 6, C and D): both
require receptor binding and the presence of
Ca2+e, and both are insensitive to
La3+. It seems likely that inositol trisphosphate, a
product of PLC action, could trigger mobilization of Ca2+
from intracellular stores. Whether the initial local increase in
[Ca2+]i is sufficient to stimulate
exocytosis (45) or whether it causes activation of store-operated
Ca2+ channels and subsequent amplification of free
[Ca2+]i remains the subject of
future studies, as does the exact nature of these Ca2+ stores.
Which of the two LTX receptors may be involved in the two phases of AA
release? Activation of PLC and mobilization of
Ca2+i, which underlie LTX-evoked NE
secretion (8) and the fast AA release, can be mediated by the
heptahelical LPH coupled to G Two Distinct SV Pools--
The most interesting distinction
between the two phases of LTX-evoked
Ca2+-dependent release is their differential
sensitivity to PAO and loading time, implicating physiologically
distinct vesicular pools.
When synaptosomes are loaded with radiolabeled AAs, the
sucrose-sensitive RRP accumulates the label very quickly, in parallel with AA uptake into the cytosol. In contrast, the time necessary to
load the second SV pool (Fig. 1A) appears surprisingly long (1-2 h) compared with ~20 s required for recovery of vesicles after
stimulation (46). However, without stimulation, the endogenous NT
present in some vesicles must prevent their loading with labeled cytosolic AAs. Thus, if a vesicular pool is emptied infrequently, it
will be labeled only after a considerable delay. This consideration justifies our loading paradigm and supports the idea that the slow-loading SVs belong to the resting (depot) pool.
If synaptosomes are treated with PAO (inhibitor of PI 4-kinase, which
participates in priming of vesicles for release) (31) and then loaded
with radiolabeled AAs, release will be detected only from those
vesicles that have passed the priming step prior to drug addition. Such
SVs can be specifically released by sucrose (Fig. 7C), which
only stimulates the RRP (32, 33), and by LTX (fast
Ca2+-dependent phase, Fig. 7, D and
E). We demonstrate that these two types of release occur
from a common SV pool (Fig. 8, C, F, G, and J). Thus, the fast-loading vesicles
insensitive to PAO must belong to the RRP. The size of this pool
determined here is 6-8% of the total radioactive AA content, and this
probably includes both the morphologically docked and near-membrane SVs (47).
On the other hand, Ca2+-dependent AA release
induced by the delayed (pore-mediated) LTX action, by high
K+/Ca2+, or by A23187 is sensitive to PAO (Fig.
7, A, B, and F), suggesting that it
occurs from SVs that still need priming by PI 4-kinase. However, such
release is absent in short-loaded synaptosomes (Figs. 1A and
7G), implying that: (i) the PAO-sensitive vesicles do not accumulate radiolabeled AAs during a short loading, and (ii) LTX pore
acts on an SV pool distinct from the RRP. Because this pool contains
unprimed and slow-loading SVs, it probably represents the depot pool.
The two SV pools are differentially regulated by the two
Ca2+-dependent LTX mechanisms. The
receptor-mediated pathway triggers rapid fusion of the RRP (probably by
increasing local [Ca2+]i) but does
not induce fusion of the depot vesicles. The latter may require
sufficient Ca2+ entering via LTX pores (Fig.
6A). In gonadotrophs too, Ca2+ release from
stores causes fast exocytosis, whereas a universal rise in
[Ca2+]i induces only a slow
granule fusion (45).
Can the depot vesicles be released separately, or do they become
readily releasable prior to exocytosis? After repeated 4-s applications
of hypertonic solutions or high frequency electrical stimulation, the
RRP is depressed for 3-4 min (36). Similarly, in our experiments, once
the RRP is released by a 90-s treatment with sucrose or by
LTXN4C, replacement vesicles sensitive to these stimuli are
not immediately available (Fig. 8, A-C, F,
G, and J). Importantly, in such overstimulated synaptosomes, the LTX pore can still induce delayed
Ca2+-dependent release (e.g. Fig.
8D) of vesicles that are sensitive to PAO but not to
sucrose, indicating that the depot vesicles can be released
independently, without necessarily becoming readily releasable.
Conclusions--
Our results indicate that LTX can be successfully
used only when carefully separating out its diverse actions. We
demonstrate that LTXN4C is a very useful probe for
elucidating the receptor-mediated actions. An important implication of
our findings is that the readily releasable vesicles can be selectively
regulated via the LTX receptors; the mechanism of this regulation can
now be studied using the mutant toxin.
-Latrotoxin stimulates three types of
[3H]
-aminobutyric acid and
[14C]glutamate release from synaptosomes. The
Ca2+-independent component (i) is insensitive to SNAP-25
cleavage or depletion of vesicle contents by bafilomycin A1 and
represents transmitter efflux mediated by
-latrotoxin pores. Two
other components of release are Ca2+-dependent
and vesicular but rely on distinct mechanisms. The fast
receptor-mediated pathway (ii) involves intracellular Ca2+
stores and acts upon sucrose-sensitive readily releasable vesicles; this mechanism is insensitive to inhibition of phosphatidylinositol 4-kinase (PI 4-kinase). The delayed pore-dependent
exocytotic component (iii) is stimulated by Ca2+ entering
through
-latrotoxin pores; it requires PI 4-kinase and occurs mainly
from depot vesicles. Lanthanum perturbs
-latrotoxin pores and blocks
the two pore-mediated components (i, iii) but not the receptor-mediated
release (ii).
-Latrotoxin mutant (LTXN4C) cannot form
pores and stimulates only the Ca2+-dependent
receptor-mediated amino acid exocytosis (ii) (detectable biochemically
and electrophysiologically). These findings explain experimental data
obtained by different laboratories and implicate the toxin receptors in
the regulation of the readily releasable pool of synaptic vesicles. Our
results also suggest that, similar to noradrenergic vesicles,
amino acid-containing vesicles at some point in their cycle
require PI 4-kinase.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-Latrotoxin (LTX)1
causes massive release of neurotransmitters (NTs) and is widely used to
study exocytosis of synaptic and large dense-cored vesicles in neuronal
and endocrine cells (1-4).
-aminobutyric acid (GABA) and to distinguish the pore- and
receptor-dependent LTX actions. To avoid the toxin pore
formation, we employed La3+ (which disrupts toxin
tetramers) and a mutant LTX (which is unable to form such tetramers).
The use of Botulinum neurotoxin type E (BoNT/E) and
bafilomycin A1 (BAF) allowed us to identify true SV exocytosis. We
demonstrate that, in the absence of Ca2+, LTX causes
predominantly nonvesicular AA efflux. Toxin-evoked vesicular AA release
is detectable biochemically only in the presence of Ca2+
and is based on two pharmacologically and temporally distinct mechanisms: (i) fast receptor-mediated phase that acts upon readily releasable SVs and (ii) delayed pore-mediated Ca2+ entry
that stimulates depot vesicles. Our study confirms the differential
regulation of the two vesicular pools and demonstrates the usefulness
of mutant LTX for in-depth studies of AA release.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-Latrotoxin was purified from spider venom
(19). Pure BoNT/E was a kind gift of Prof. J. O. Dolly.
[2,3-3H]GABA, L-[U-14C]Glu, and
45Ca2+ were from Amersham Pharmacia Biotech.
Thapsigargin (TG), BAPTA-AM, and U73122 were from Calbiochem; all other
reagents were from Sigma.
70 mV), were made from CA3 pyramidal neurons using an
Axoclamp 2A amplifier (Axon Instruments), at a sampling frequency of
100 µs (12 bits). Patch pipettes (2-4 megohms) contained
intracellular solution (in mM): 110 potassium gluconate, 10 KCl, 4 MgCl2, 50 HEPES, 4 Na2-ATP, 0.2 Na2-GTP, 10 creatine phosphate (pH 7.3). After 20 min in
the whole-cell mode, perfusion was stopped, and 1 µM
tetrodotoxin and 10 µM bicuculline were added to the bath to block action potentials and GABA-induced postsynaptic currents. Spontaneous Glu-induced miniature excitatory postsynaptic currents (mEPSCs) were recorded for 10-20 min before and after the addition of
0.5 nM LTXN4C. MiniAnalysis software
(Synaptosoft) was used to analyze the traces.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (28K):
[in a new window]
Fig. 1.
Optimization of conditions for measuring AA
release from nerve terminals. A and B,
optimal time for loading terminals with radiolabeled AAs. Rat
synaptosomes were incubated with [14C]Glu at 37 °C for
5 min, washed, and kept at 37 °C for indicated times prior to a
final wash and a 1-min stimulation with 25 mM
K+ ± 2.5 mM Ca2+. The
Ca2+-dependent release (A) was
determined by subtracting the release evoked in the absence of
Ca2+ (B) from the total release in the presence
of Ca2+. C and D, time courses and
termination of Ca2+-dependent and -independent
components of LTX-stimulated [14C]Glu release.
Synaptosomes were loaded with [14C]Glu by the normal
protocol. Control release (CON) was triggered by 3 nM LTX in the presence of 1.2 mM
Ca2+ or 0.1 mM EGTA. Addition of 1.3 mM EGTA or 0.2 mM La3+,
respectively, blocked any further release (arrows). For
statistics, see "Experimental Procedures"; all results are from two
independent experiments done in triplicate.

View larger version (29K):
[in a new window]
Fig. 2.
Three types of LTX-induced AA release.
A and B, time courses of
Ca2+-independent release of [14C]Glu and
[3H]GABA. 3 nM LTX was added to loaded
synaptosomes with 0.1 mM free La3+ (open
circles) or without it (closed circles), in the
presence of 0.1 mM EGTA. Release was measured as described
under "Experimental Procedures" and the data plotted incrementally,
i.e. as release occurring between consecutive 1-min
intervals. C-F, time courses of
Ca2+-dependent LTX-evoked release in the
presence or absence of 0.1 mM La3+.
Synaptosomes were loaded with radiolabeled AAs and stimulated by 3 nM LTX for [14C]Glu and 2 nM LTX
for [3H]GABA, in the presence of various
[Ca2+]e (right). Release was
stopped at given times; the Ca2+-dependent
component of LTX action was determined as in Fig. 1 and expressed
incrementally. The two phases of this release (underlined
below) were determined as outlined under "Experimental
Procedures." G and H, the Ca2+
dependence of the two phases of LTX-evoked [14C]Glu and
[3H]GABA release, respectively. The numbers of
independent experiments done in triplicates were four (A,
C, E, and G), five (B),
three (D and F), and two (H).

View larger version (39K):
[in a new window]
Fig. 3.
The mechanism of La3+-induced
inhibition of LTX actions. A, LTX pores are blocked by
La3+ directly and reversibly. BHK cells expressing LPH were
voltage-clamped (
60 mV), and whole-cell currents recorded (inward
currents downward). A local superfusion system was activated when
indicated by bars. A manually applied dose of
LaCl3 (10 µl, 1 mM, arrow)
reversibly blocked the LTX-induced pores, which reappeared on washout.
B, the number of LTX tetramers (4×) and dimers (2×) found
in the absence or presence of 0.1 mM La3+.
Vitrified samples were imaged by cryo-EM. Four micrographs were
analyzed for each condition; the numbers of LTX dimers and tetramers
found were expressed as percentages of the total number of individual
molecular images. C, characteristic top views of LTX
tetramers in the absence and presence of La3+. The numbers
of independent experiments were five (A) and two
(B and C); the number of individual images in
C was ~800 for control and 84 for La3+-treated
LTX.
3 Å in the presence of
La3+) (Fig. 3C).

View larger version (33K):
[in a new window]
Fig. 4.
Only the
Ca2+-dependent LTX-induced release is
vesicular. A-F, intact SNAP-25 and vesicular AAs are
required for Ca2+-dependent secretion triggered
by various stimuli. G and H, neither the cleavage
of SNAP-25 nor depletion of NT from vesicles perturbs the
Ca2+-independent LTX-evoked release. I-L, both
the fast and delayed phases of LTX-stimulated
Ca2+-dependent release are exocytotic.
Terminals were incubated at 37 °C with radiolabeled AAs for 10 min
(the times of drug addition are indicated under "Experimental
Procedures"), washed, and stimulated for 1 min by high K+
(A and B) or 5 µM A23187
(C and D), or for 5 min by 5 nM LTX
(E-L), in the presence of 0.1 mM EGTA
(G and H) or Ca2+ (2.5 mM
in A and B; 1.2 mM in C-F
and I-L). Release was determined as in Figs. 1 and 2 and
expressed as percentage of control; control values were (percentages of
the total AA content): A, 4.5; B, 3.9;
C, 3.9; D, 5.5; E, 7.7; F,
7.3; G, 13.3; H, 11.8; I, 4.1;
J, 4.0; K, 3.7; L, 6.9. All results
are from two experiments done in triplicate.

View larger version (33K):
[in a new window]
Fig. 5.
The role of cytosolic Ca2+,
internal Ca2+ stores, and PLC in the two phases of
Ca2+-dependent LTX-evoked secretion.
A and B, the
Ca2+-dependent release stimulated over 1 min by
25 mM K+, 2.5 mM Ca2+.
C and D, same for 5 µM A23187, 1.2 mM Ca2+. E-G, fast
Ca2+-dependent component of LTX-stimulated
release (phase 1). H-J, delayed phase of
Ca2+-dependent LTX-evoked release (phase 2).
K-M, Ca2+-independent LTX-evoked release
measured in the presence of 0.1 mM EGTA over 5 min. Where
indicated, drugs were added during the post-loading incubation of
synaptosomes (see "Experimental Procedures"). 3 nM LTX
was used for [14C]Glu and 2 nM for
[3H]GABA release. Components of release were determined
as in Figs. 1 and 2. The numbers of independent experiments done in
quadruplicate were two (A-D), three (E,
H, and K), and four (F, G,
I, J, L, and M).

View larger version (37K):
[in a new window]
Fig. 6.
Mutant LTXN4C fails to form pores
but still evokes the Ca2+-dependent
receptor-mediated exocytosis. A, LTXWT
forms cation-permeable membrane pores, whereas LTXN4C does
not. Synaptosomes were equilibrated with 2 mM
45Ca2+/Ca2+ and exposed to 3 nM LTXWT or LTXN4C; radioactive
uptake was determined at different times. B,
electrophysiological detection of channel formation by
LTXWT. Whole-cell voltage-clamp current recordings were
done on BHK cells expressing LPH (see Fig. 3). Main trace, 1 nM LTXN4C or LTXWT was added by
superfusion as indicated by bars; hatched
bars indicate wash periods. Inset, expanded main
trace at the outset of LTXWT pore formation (two distinct
channels are visible). C-H, components of NT release
triggered by LTXWT and LTXN4C. Release from
loaded synaptosomes was determined as in Fig. 2; both recombinant
toxins were used at 2.5 nM for [3H]GABA and 4 nM for [14C]Glu. The
Ca2+-independent efflux was measured over 5 min.
I, LTXN4C causes a massive increase in the
frequency of mEPSCs in rat hippocampal slices. Glu-mediated mEPSCs were
recorded from hippocampal sections in the presence of 2 mM
Ca2+ before or 1 min after the addition of 0.5 nM LTXN4C. J, cumulative probability
distributions of mEPSC amplitudes, demonstrating that
LTXN4C does not change the amplitude of mini-events.
K, cumulative probability distributions of inter-event
intervals, showing that LTXN4C dramatically shortens the
intervals between mEPSCs. The data in A are from a
representative experiment done in triplicate; other data are from
sextuplet determinations in two (C, E, G) or one
(D, F, and H) independent experiments
(three preparations of recombinant toxins); B and
I are representative traces (n = 5);
J, Kolmogorov-Smirnov's two-tailed p > 0.5, n = 502 events for both samples; K,
p < 0.00001, n = 500 intervals.

View larger version (34K):
[in a new window]
Fig. 7.
The two
Ca2+-dependent phases of LTX-induced exocytosis
occur from vesicular pools with different PI 4-kinase requirements and
rates of AA uptake. A and B,
Ca2+-dependent [14C]Glu release
evoked over 1 min by 25 mM K+, 2.5 mM Ca2+ or 5 µM A23187, 1.2 mM Ca2+. C, [14C]Glu
release evoked by 150 mM sucrose over 90 s in 0.1 mM EGTA. D-G, the
Ca2+-dependent components of LTX-evoked
[14C]Glu release measured as in Fig. 2 in the absence or
presence of PAO or TG. H and I,
Ca2+-independent LTX-stimulated [14C]Glu
efflux over 5 min. Synaptosomes were loaded with radiolabeled AAs using
normal (A-D, F, and H) or short
(E, G, and I) protocols
(outlined under "Experimental Procedures"). In the normal protocol,
3 µM PAO was added for the last 15 min of the
post-loading incubation. In the short procedure, synaptosomes were
incubated at 37 °C with TG (10 µM) for 25 min or with
PAO (3 µM) for 10 min prior to the addition of
[14C]Glu for 5 min, washed, and release was measured 20 min later. 3 nM LTX was used for [14C]Glu.
Similar results were obtained with [3H]GABA. The results
are from quadruplicate to sextuplet determinations; the numbers of
independent experiments were four (A-D, F, and
H) and two (E, G, and
I).

View larger version (33K):
[in a new window]
Fig. 8.
Prestimulation of terminals with sucrose or
high K+ perturb only the fast
Ca2+-dependent LTX-evoked exocytosis.
Top, the scheme of experiment. Synaptosomes were loaded with
[14C]Glu or [3H]GABA using the normal
(A and C-F) or short (B and
G-N) loading protocol. The terminals were stimulated first
(as shown below the graphs) for 3-90 s with 150 mM sucrose, 0.1 mM EGTA (SUC), for 5 min with 2 nM LTXN4C, 2.5 mM
Ca2+ (N4C), or for 1 min with 25 mM
K+, 2.5 mM Ca2+
(K+) and washed. The second stimulus (indicated
above the graphs: 150 mM sucrose, 0.1 mM EGTA for 30 s or 2 nM LTX, 2.5 mM Ca2+ or 0.1 mM EGTA for 5 min)
was applied 4 min later. A and B, effect of a
variable length first hypertonic stimulation on subsequent
sucrose-triggered release of [14C]Glu in terminals loaded
by the normal or short procedure (as indicated). C-E and
G-I, effect of a 90-s first stimulation with sucrose
on the various types of [14C]Glu release evoked by LTX.
F and J, effect of prestimulation with
LTXN4C on subsequent sucrose-stimulated
[14C]Glu release. K-N, effect of
predepolarization with high K+ on subsequent LTX- or
sucrose-evoked secretion. The results are from three independent
experiments done in sextuplet.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
q (18). On the other hand,
both LPH and NRX (or even their nonsignaling mutants) can mediate the
pore-dependent phase 2 (9, 10); this explains the results
used to speculate that LTX acts without receptor activation (43). The
future use of LTXN4C should help to determine the role of
each receptor in LTX action.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Oliver Dolly for the gift of BoNT/E and Eugene Grishin for the anti-LTX monoclonal antibody.
| |
FOOTNOTES |
|---|
* This work was supported by a Wellcome Trust senior European research fellowship (to Y. A. U.) and by grants from the CNRS (to C. V. R. and M. S.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§ Present address: Dept. of Crystallography, Birkbeck College, London WC1E 7HX, United Kingdom.
** To whom correspondence should be addressed. Tel.: 44-20-594-5237; Fax: 44-20-594-5207; E-mail: y.ushkaryov@ic.ac.uk.
Published, JBC Papers in Press, September 25, 2001, DOI 10.1074/jbc.M108088200
2 K. E. Volynski and Y. A. Ushkaryov, unpublished observations.
3 K. E. Volynski, D. Thomson, E. V. Orlove, C. Manser, A. C. Ashton, R. R. Ribchester, and Y. A. Ushkaryov, manuscript in preparation.
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
LTX,
-latrotoxin;
AA, amino acid(s);
BAF, bafilomycin A1;
BAPTA, 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic
acid;
BHK, baby hamster kidney;
BoNT, Botulinum neurotoxin;
cryo-EM, cryo-electron microscopy;
GABA,
-aminobutyric acid;
Glu, L-glutamic acid;
LPH, latrophilin;
mEPSC, miniature
excitatory postsynaptic currents;
NE, norepinephrine;
NRX, neurexin;
NT, neurotransmitter;
PAO, phenylarsine oxide;
PB, physiological
buffer;
PLC, phospholipase C;
RRP, readily releasable pool;
SV, synaptic vesicle;
TG, thapsigargin.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Ceccarelli, B., and Hurlbut, W. P. (1980) J. Cell Biol. 87, 297-303 |
| 2. | Capogna, M., Gahwiler, B. H., and Thompson, S. M. (1996) J. Neurophysiol. 76, 3149-3158 |
| 3. | Rosenthal, L., Zacchetti, D., Madeddu, L., and Meldolesi, J. (1990) Mol. Pharmacol. 38, 917-923 |
| 4. | Liu, J., and Misler, S. (1998) J. Neurosci. 18, 6113-6125 |
| 5. | Ushkaryov, Y. A., Petrenko, A. G., Geppert, M., and Sudhof, T. C. (1992) Science 257, 50-56 |
| 6. | Lelianova, V. G., Davletov, B. A., Sterling, A., Rahman, M. A., Grishin, E. V., Totty, N. F., and Ushkaryov, Y. A. (1997) J. Biol. Chem. 272, 21504-21508 |
| 7. | Hurlbut, W. P., Chieregatti, E., Valtorta, F., and Haimann, C. (1994) J. Membr. Biol. 138, 91-102 |
| 8. | Davletov, B. A., Meunier, F. A., Ashton, A. C., Matsushita, H., Hirst, W. D., Lelianova, V. G., Wilkin, G. P., Dolly, J. O., and Ushkaryov, Y. A. (1998) EMBO J. 17, 3909-3920 |
| 9. | Van Renterghem, C., Iborra, C., Martin-Moutot, N., Lelianova, V., Ushkaryov, Y., and Seagar, M. (2000) Eur. J. Neurosci. 12, 3953-3962 |
| 10. | Volynski, K. V., Meunier, F. A., Lelianova, V. G., Dudina, E. E., Volkova, T. M., Rahman, M. A., Manser, C., Grishin, E. V., Dolly, J. O., Ashley, R. H., and Ushkaryov, Y. A. (2000) J. Biol. Chem. 275, 41175-41183 |
| 11. | Fesce, R., Segal, J. R., Ceccarelli, B., and Hurlbut, W. P. (1986) J. Gen. Physiol. 88, 59-81 |
| 12. | Auger, C., and Marty, A. (1997) Neuron 19, 139-150 |
| 13. | McMahon, H. T., Rosenthal, L., Meldolesi, J., and Nicholls, D. G. (1990) J. Neurochem. 55, 2039-2047 |
| 14. | Deri, Z., Bors, P., and Adam-Vizi, V. (1993) J. Neurochem. 60, 1065-1072 |
| 15. | Okamoto, M., Longenecker, H. E., Jr., Riker, W. F., Jr., and Song, S. K. (1971) Science 172, 733-736 |
| 16. | Watanabe, O., Torda, M., and Meldolesi, J. (1983) Neuroscience 10, 1011-1024 |
| 17. | Orlova, E. V., Rahman, M. A., Gowen, B., Volynski, K. E., Ashton, A. C., Manser, C., van Heel, M., and Ushkaryov, Y. A. (2000) Nat. Struct. Biol. 7, 48-53 |
| 18. | Rahman, M. A., Ashton, A. C., Meunier, F. A., Davletov, B. A., Dolly, J. O., and Ushkaryov, Y. A. (1999) Philos. Trans. R. Soc. Lond. B Biol. Sci. 354, 379-386 |
| 19. | Ashton, A. C., Rahman, M. A., Volynski, K. E., Manser, C., Orlova, E. V., Matsushita, H., Davletov, B. A., van Heel, M., Grishin, E. V., and Ushkaryov, Y. A. (2000) Biochimie (Paris) 82, 453-468 |
| 20. | Ashton, A. C., and Dolly, J. O. (2000) J. Neurochem. 74, 1979-1988 |
| 21. | Khvotchev, M., and Sudhof, T. C. (1998) J. Biol. Chem. 273, 21451-21454 |
| 22. | Zhou, Q., Petersen, C. C., and Nicoll, R. A. (2000) J. Physiol. (Lond.) 525, 195-206 |
| 23. | Irving, A. J., and Collingridge, G. L. (1998) J. Physiol. (Lond.) 511, 747-759 |
| 24. | Savic, N., and Sciancalepore, M. (1998) Eur. J. Neurosci. 10, 3379-3386 |
| 25. | Verhage, M., Sandman, H., Mosselveld, F., van de Velde, M., Hengst, P. A., Lopes da Silva, F. H., and Ghijsen, W. E. (1992) J. Neurochem. 58, 1313-1320 |
| 26. | Volynski, K. E., Nosyreva, E. D., Ushkaryov, Y. A., and Grishin, E. V. (1999) FEBS Lett. 442, 25-28 |
| 27. | Ichtchenko, K., Khvotchev, M., Kiyatkin, N., Simpson, L., Sugita, S., and Sudhof, T. C. (1998) EMBO J. 17, 6188-6199 |
| 28. | Sihra, T. S., and Nicholls, D. G. (1987) J. Neurochem. 49, 261-267 |
| 29. | Wilkinson, R. J., and Nicholls, D. G. (1989) Neurochem. Int. 15, 191-197 |
| 30. | Scheer, H. W. (1989) J. Neurochem. 52, 1590-1597 |
| 31. | Wiedemann, C., Schafer, T., Burger, M. M., and Sihra, T. S. (1998) J. Neurosci. 18, 5594-5602 |
| 32. | Rosenmund, C., and Stevens, C. F. (1996) Neuron 16, 1197-1207 |
| 33. | Lonart, G., and Sudhof, T. C. (2000) J. Biol. Chem. 275, 27703-27707 |
| 34. | Verhage, M., Lopes da Silva, F. H., and Ghijsen, W. E. (1991) Neuroscience 43, 59-66 |
| 35. | Ashton, A. C., and Dolly, J. O. (1997) J. Neurochem. 68, 649-658 |
| 36. | Stevens, C. F., and Wesseling, J. F. (1999) Neuron 24, 1017-1028 |
| 37. | Nicholls, D. G. (1989) J. Neurochem. 52, 331-341 |
| 38. | Bittner, M. A., Krasnoperov, V. G., Stuenkel, E. L., Petrenko, A. G., and Holz, R. W. (1998) J. Neurosci. 18, 2914-2922 |
| 39. | Bittner, M. A., and Holz, R. W. (2000) J. Biol. Chem. 275, 25351-25357 |
| 40. | Misler, S., and Falke, L. C. (1987) Am. J. Physiol. 253, C469-C476 |
| 41. | Sudhof, T. C. (1995) Nature 375, 645-653 |
| 42. | McMahon, H. T., and Nicholls, D. G. (1991) J. Neurochem. 56, 86-94 |
| 43. | Sugita, S., Ichtchenko, K., Khvotchev, M., and Südhof, T. C. (1998) J. Biol. Chem. 273, 32715-32724 |
| 44. | Khvotchev, M., and Sudhof, T. C. (2000) EMBO J. 19, 3250-3262 |
| 45. | Tse, F. W., Tse, A., Hille, B., Horstmann, H., and Almers, W. (1997) Neuron 18, 121-132 |
| 46. | Stevens, C. F., and Tsujimoto, T. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 846-849 |
| 47. | Richards, D. A., Guatimosim, C., and Betz, W. J. (2000) Neuron 27, 551-559 |